A recent GWAS of white matter biomarkers in cerebrovascular disease has also revealed alterations in immune cell genes including human leukocyte antigen B (HLA‐B), major histocompatibility complex I (MHC I and HLA‐S), cell‐surface proteins involved in immune system regulation (Persyn et al., 2020). This evidence concerns the gene HLA-B and cerebrovascular disorder.